The Free Press
NewslettersSign InSubscribe
It’s Time to Clear the Air on Juul
In the decade since it became a hot product, Juul has been to hell and back. The FDA may have just resurrected it. (Photo illustration by The Free Press; image via Getty)
Juul spent the last five years in purgatory thanks to its popularity with teens. With the FDA’s authorization last week, it can finally be seen for what it’s always been: a harm-reduction device.
By Joe Nocera
07.23.25 — Health and Self-Improvement
--:--
--:--
Upgrade to Listen
5 mins
Produced by ElevenLabs using AI narration
61
52

Last week, after a five-year delay, the Food and Drug Administration finally authorized the marketing of Juul’s e-cigarettes. To my great surprise, there was very little outcry.

Oh sure, the Campaign for Tobacco-Free Kids, which has waged war against Juul for nearly a decade, called the authorization “a big step backward for preventing youth e-cigarette use,” and the American Lung Association said it was “deeply troubled” by the decision. But only one legislator of note, Senator Dick Durbin of Illinois, a Democrat, took the opportunity to criticize the decision, while the American Cancer Society, another Juul hater, didn’t even bother to put out a press release.

The Free Press mobile app is here! The Free Press app gives you access to everything we write, record, and film, all in one place. It’s fast and easy to use, and the best way to make sure you never miss a Free Press story.

Download The Free Press App Today

There is a good reason for this lack of outrage—two, in fact. The first is that the so-called “youth vaping crisis,” in which Juul was accused of hooking kids on nicotine, has vanished. In 2019, according to the Centers for Disease Control and Prevention (CDC), 27.5 percent of high-school students had vaped during the previous 30 days, with the sleek Juul e-cigarette by far the most popular brand. Last year, the CDC reported that the percentage of high-school students who vaped had dropped to 5.9 percent—with fewer than one percent using a Juul product, the company says.

Limited Time Offer
Get 25% off an annual subscription to The Free Press.
Already have an account? Sign in
To read this article, sign in or subscribe
Joe Nocera
Joe Nocera is an editor and writer at The Free Press. During his long career in journalism, he has been a columnist at The New York Times, Bloomberg, Esquire, and GQ, the editorial director of Fortune, and a writer at Newsweek, Texas Monthly and The Washington Monthly. He was a finalist for the Pulitzer Prize in 2007.
Tags:
Health
Business
Comments
Join the conversation
Share your thoughts and connect with other readers by becoming a paid subscriber!
Already a paid subscriber? Sign in

No posts

For Free People.
LatestSearchAboutCareersShopPodcastsVideoEvents
Download the app
Download on the Google Play Store
©2025 The Free Press. All Rights Reserved.Powered by Substack.
Privacy∙Terms∙Collection notice